✦ LIBER ✦

What Role Do Combinations of Interferon and Targeted Agents Play in the First-Line Therapy of Metastatic Renal Cell Carcinoma?

✍ Scribed by Ronald M. Bukowski

Book ID: 119935418
Publisher: CIG Media Group, LP.
Year: 2008
Tongue: English
Weight: 147 KB
Volume: 6
Category: Article
ISSN: 1558-7673
DOI: 10.3816/cgc.2008.s.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of combination interferon

Phase II trial of combination interferon-alpha and thalidomide as first-line therapy in metastatic renal cell carcinoma

✍ Peter E. Clark; M.Craig Hall; Antonius Miller; Kevin P. Ridenhour; Diana Stindt; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 114 KB

The association of clinical outcome to f

The association of clinical outcome to first-line VEGF-targeted therapy with clinical outcome to second-line VEGF-targeted therapy in metastatic renal cell carcinoma patients

✍ Mhd Y. Al-Marrawi, Brian I. Rini, Lauren C. Harshman, Georg Bjarnason… 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 269 KB

Targeted therapies and complete response

Targeted therapies and complete responses in first line treatment of metastatic renal cell carcinoma. A meta-analysis of published trials

✍ Iacovelli, Roberto; Alesini, Daniele; Palazzo, Antonella; Trenta, Patrizia; Sant 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 747 KB

1140 Categories of response to first lin

1140 Categories of response to first line VEGF receptor targeted therapy and overall survival in patients with metastatic renal cell carcinoma

✍ Busch, J.F.; Seidel, C.; Goranova, I.; Erber, B.; Peters, R.; Friedersdorff, F.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 108 KB

2003 ANTITUMOR ACTIVITY OF SUNITINIB VER

2003 ANTITUMOR ACTIVITY OF SUNITINIB VERSUS OTHER FDA-APPROVED TARGETED CANCER AGENTS AGAINST METASTATIC RENAL CELL CARCINOMA IN THE FIRST-LINE SETTING

✍ Rampersaud, Edward N.; Birkhauser, Frederic D.; Logan, Joshua E.; Sonn, Geoffrey 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 157 KB

To combine or not combine: the role of r

To combine or not combine: the role of radiotherapy and targeted agents in the treatment for renal cell carcinoma

✍ Weiss, Christian; Schulze, BjÃ¶rn; Ottinger, Annette; RÃ¶del, Claus 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 859 KB